Hudson Edge Investment Partners’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-8,953
Closed -$5.2M 200
2024
Q1
$5.2M Sell
8,953
-1,473
-14% -$827K 1.02% 48
2023
Q4
$5.53M Buy
10,426
+788
+8% +$381K 1.29% 28
2023
Q3
$4.88M Sell
9,638
-806
-8% -$429K 1.59% 39
2023
Q2
$5.45M Buy
10,444
+1,558
+18% +$841K 1.73% 31
2023
Q1
$5.12M Buy
+8,886
New +$5.01M 1.59% 40

Other funds holding TMO

Hudson Edge Investment Partners's TMO Position: Q2 2024 in Review

Hudson Edge Investment Partners sold out of Thermo Fisher Scientific (TMO) in Q2 2024, closing a stake of 8,953 shares — an estimated $5.2M sold.

Hudson Edge Investment Partners first reported a position in TMO in Q1 2023 and held it in 5 quarters. The position peaked at $5.53M in Q4 2023. 2,542 funds tracked by Wall St. Rank hold TMO as of Q2 2024.

  • Hudson Edge Investment Partners reported no remaining Thermo Fisher Scientific position as of Q2 2024 after selling out during the quarter.
  • Hudson Edge Investment Partners sold 8,953 Thermo Fisher Scientific shares in Q2 2024, an estimated $5.2M.
  • Hudson Edge Investment Partners first reported a position in Thermo Fisher Scientific in Q1 2023 and held it in 5 quarters.
  • Hudson Edge Investment Partners's Thermo Fisher Scientific position peaked at $5.53M in Q4 2023.
  • 2,542 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2024.

Based on Hudson Edge Investment Partners's 13F filing for Q2 2024, filed 6 Aug 2024.